Form 4: Marimed Inc. COO Timothy Shaw Reports Stock Transactions

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, along with holdings in a family trust.

Summary

• On March 7, 2025, Timothy Shaw, the Chief Operating Officer of Marimed Inc., reported transactions involving the company's common stock.
• 21,667 Restricted Stock Units (RSUs) vested and converted into common stock.
• 7,508 shares were withheld by the issuer to cover tax obligations related to the RSU vesting at a price of $0.1098 per share.
• Following these transactions, Shaw directly owns 8,790,264 shares of common stock.
• Shaw also indirectly owns 2,000,000 shares through the Shaw Family Trust, for which his spouse is the trustee and the beneficiaries are his children; he disclaims beneficial ownership of these shares.
• The RSUs were granted on March 7, 2023, and vest in installments through March 7, 2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest in two equal installments on September 7, 2025, and March 7, 2026.

Management Comments

• The reporting person disclaims beneficial ownership of the securities held in the Shaw Family Trust.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• Shareholders are informed about the insider transactions of a key executive.

Key Dates